X23-10-ZQ514 |
CXCR antagonist Plerixafor 8HCl, Purity ≥98%
|
|
X23-10-ZQ516 |
CXCR inhibitor SRT3109, Purity ≥98%
|
|
X23-10-ZQ520 |
CXCR inhibitor AMD 070, Purity ≥98%
|
|
X23-10-ZQ526 |
CXCR antagonist SCH-527123, Purity ≥98%
|
|
X23-10-ZQ527 |
CXCR inhibitor SRT3190, Purity ≥98%
|
|
X23-10-ZQ542 |
CXCR antagonist AMD 3465 Hexahydrobromide, Purity ≥98%
|
|
X23-10-ZQ550 |
CXCR inhibitor Reparixin, Purity ≥98%
|
|
X23-10-ZQ552 |
GPR35 agonist 1, Purity ≥98%
|
|
X23-10-ZQ558 |
CXCR inhibitor WZ811, Purity ≥98%
|
|
X23-10-ZQ559 |
CXCR inhibitor MSX-122, Purity ≥98%
|
|
X23-10-ZQ560 |
CXCR inhibitor CXCR2-IN-1, Purity ≥98%
|
|
X23-10-ZQ571 |
CXCR inhibitor AMD3100, Purity ≥98%
|
|
X23-10-ZQ596 |
CXCR inhibitor SB265610, Purity ≥98%
|
|
X23-10-ZQ598 |
CXCR inhibitor SB225002, Purity ≥98%
|
|
X23-10-ZQ607 |
CXCR inhibitor AMD-070 HCl, Purity ≥98%
|
|
X23-10-ZQ610 |
CXCR inhibitor Reparixin L-lysine salt, Purity ≥98%
|
|
X23-10-ZQ612 |
CXCR inhibitor SCH 563705, Purity ≥98%
|
|
X23-10-ZQ618 |
CXCR inhibitor UNBS5162, Purity ≥98%
|
|
X23-10-ZQ629 |
CXCR inhibitor AZD-5069, Purity ≥98%
|
|
X23-10-ZQ640 |
CXCR inhibitor ATI-2341, Purity ≥98%
|
|